BA
50
-2
BAX
30
-5
QRVO
25
3
AN
49
-5
SIG
47
-3
ES
55
-7
IVZ
58
6
GOOG
67
-4
HUM
24
3
APH
52
-3
CTAS
55
3
AZO
43
-7
WMT
60
-2
ETN
73
-2
MRK
28
-5
KO
44
-5
DVA
71
-4
PSX
40
3
FMC
41
-5
AMG
36
3
BA
50
-2
BAX
30
-5
QRVO
25
3
AN
49
-5
SIG
47
-3
ES
55
-7
IVZ
58
6
GOOG
67
-4
HUM
24
3
APH
52
-3
CTAS
55
3
AZO
43
-7
WMT
60
-2
ETN
73
-2
MRK
28
-5
KO
44
-5
DVA
71
-4
PSX
40
3
FMC
41
-5
AMG
36
3
Financhill
Back

Denali Therapeutics Stock Predictions

Invest in the Next Big AI Disruptor Today

Learn More
Sell
43

DNLI
Denali Therapeutics

Last Price:
28.21
Seasonality Move:
20.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Supercharge Your Portfolio with This High-Traction AI Startup

Learn More

Denali Therapeutics Stock Forecast

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 19.3% based on the past 6 years of stock performance.
  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Denali Therapeutics Stock Undervalued?
    The current Denali Therapeutics [DNLI] share price is $29.03. The Score for DNLI is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 19.3% based on the past 6 years of stock performance.

Denali Therapeutics Stock Rating

Sell
43
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics overpriced?

  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

  • The current trend is moderately bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com

52-Week Data

52-Week High:
32.13
52-Week Low:
14.56

Prediction Charts

Market Cap:
4.16B
Price in USD:
29.03
Volume:
541.47K
Beta:
1.56

Technical Analysis

SMA50:
25.75
SMA100:
23.46
SMA200:
21.10
52-Wk Change:
46.69%

Stock Predictions

  • Is Denali Therapeutics stock public?
    Yes, Denali Therapeutics is a publicly traded company.
  • What is the Denali Therapeutics stock quote today?
    The Denali Therapeutics stock price is 29.03 USD today.
  • How to buy Denali Therapeutics stock online?
    You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-13 28.00 30.77 31.00 28.00
Sep-16 30.77 30.33 30.96 30.12
Sep-17 30.61 30.68 31.15 30.19
Sep-18 30.68 30.76 32.13 30.58
Sep-19 31.70 31.08 31.94 30.82
Sep-20 30.94 30.92 31.24 30.65
Sep-23 31.23 30.24 31.28 30.23
Sep-24 30.24 30.32 30.51 29.58
Sep-25 30.52 29.00 30.54 28.93
Sep-26 29.37 29.27 29.64 28.83
Sep-27 29.50 29.43 29.80 29.22
Sep-30 29.12 29.13 29.32 28.50
Oct-1 29.18 28.69 29.67 28.46
Oct-2 28.37 29.03 29.07 28.02

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.